Elysium Pharmaceuticals Ltd - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1995.
1995 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Elysium Pharmaceuticals Ltd

Elysium Pharmaceuticals Ltd, a active public limited company, was established on 11 January 1995 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1995PLC024164. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹22.00 Cr and a paid-up capital of ₹16.00 Cr.

It upholds a compliant status. Employing 337 professional, Its leadership includes Vithalbhai Shankerbhai Patel (Director), Hiren Prakash Barot (Additional Director), Jinkal Darshan Patel (Whole-Time Director). Past directors included Ashokkumar Vallavbhai Patel, Vithalbhai Shankerbhai Patel, Mukund Laxman Abhyankar. It holds ₹81.05 Cr open charges and ₹165.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.1175, P.O. Dabhasa, Tal. Padra, Vadodara, Gujarat, 391440.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1995PLC024164

  • Registration Number

    024164

  • Incorporation Date

    11 January 1995

  • Authorized Capital

    ₹22.00 Cr

  • Paid-Up Capital

    ₹16.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 22.00 Cr
  • Paid Up Capital ₹ 16.00 Cr
  • Company Age 31 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 81.05 Cr
  • Satisfied Charges ₹ 165.22 Cr
  • Revenue Growth **** 93.92%
  • Profit Growth **** 208.42%
  • Ebitda **** 90.74%
  • Net Worth 49.63%
  • Total Assets **** 28.39%
Company report

Elysium Pharmaceuticals Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elysium Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elysium Pharmaceuticals Ltd?
Current Directors
Name Designation Appointment Date Status
Vithalbhai Shankerbhai Patel Director 21 Jun 2006 Current
Hiren Prakash Barot Additional Director 17 Feb 2025 Current
Jinkal Darshan Patel Whole-Time Director 30 Jan 2020 Current
Chandani Ankitkumar Jhanwar Director 17 Feb 2023 Current
Shitalkumar Navnitbhai Patel Whole-Time Director 30 Jan 2020 Current
Yashwantrai Chunibhai Patel Managing Director 25 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2013 Past
Pramod Abcsdd Director 30 Sep 2019 Past
Pramod Abcsdd Director 01 Apr 2013 Past
Pramod Abcsdd Director 01 Oct 2021 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elysium Pharmaceuticals.

Elysium Pharmaceuticals Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 93.92% increase. The company also saw a substantial improvement in profitability, with a 208.42% increase in profit. The company's net worth Soared by an impressive increase of 49.63%.

Elysium Pharmaceuticals revenue growth over time
Elysium Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 93.92%
*******
*******
*******
*******
Revenue from Operations
*******
 89.36%
*******
*******
*******
*******
Total Assets
*******
 28.39%
*******
*******
*******
*******
Profit or Loss
*******
 208.42%
*******
*******
*******
*******
Net Worth
*******
 49.63%
*******
*******
*******
*******
EBITDA
*******
 90.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elysium Pharmaceuticals?

In 2024, Elysium Pharmaceuticals had a promoter holding of 90.37% and a public holding of 9.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹810,500,000.00

Satisfied Charges

₹1,652,190,851.00

Charges Breakdown by Lending Institutions
  • Others : 81.05 Cr
Latest Charge Details
Date Lender Amount Status
11 Mar 2022 Others ₹18.43 Cr Open
04 Jul 2014 Others ₹31.31 Cr Open
11 Dec 2010 Others ₹31.31 Cr Open
15 Mar 2022 Others ₹2.29 Cr Satisfied
27 Oct 2021 Others ₹26.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Elysium Pharmaceuticals?

Elysium Pharmaceuticals has a workforce of 337 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elysium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elysium Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elysium Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 31 Aug 2021 via Charge ID 100483450 with Others was fully satisfied on 07 Aug 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 31.31 Cr registered on 04 Jul 2014 with Charge ID 10508871 was modified on 07 Aug 2025. was completed.

  • Charges

    A charge registered on 15 Feb 2014 via Charge ID 10480281 with State Bank Of India was fully satisfied on 07 Aug 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 31.31 Cr registered on 11 Dec 2010 with Charge ID 10257659 was modified on 07 Aug 2025. was completed.

  • Charges

    The activity A charge registered on 16 Feb 2010 via Charge ID 10209989 with State Bank Of India was fully satisfied on 07 Aug 2025. was completed.

  • Charges

    A charge registered on 03 Jul 2002 via Charge ID 80047401 with State Bank Of India was fully satisfied on 07 Aug 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elysium Pharmaceuticals Ltd?

The CIN of Elysium Pharmaceuticals Ltd is U24231GJ1995PLC024164.

Where is Elysium Pharmaceuticals Ltd headquartered?

Elysium Pharmaceuticals Ltd is headquartered at Plot No.1175, P.O. Dabhasa, Tal. Padra, Vadodara, Gujarat, 391440.

When was Elysium Pharmaceuticals Ltd incorporated?

Elysium Pharmaceuticals Ltd was incorporated on 11 January 1995.

Who are the current directors of Elysium Pharmaceuticals Ltd?

The current directors of Elysium Pharmaceuticals Ltd are

What is the primary industry of Elysium Pharmaceuticals Ltd?

The primary industry of Elysium Pharmaceuticals Ltd is Manufacturing.

Is Elysium Pharmaceuticals Ltd a listed company?

Elysium Pharmaceuticals Ltd is unlisted.

What is the capital structure of Elysium Pharmaceuticals Ltd?

The authorized capital of Elysium Pharmaceuticals Ltd is ₹22.00 Cr, and the paid-up capital is ₹16.00 Cr.

What is the compliance status of Elysium Pharmaceuticals Ltd?

The compliance status of Elysium Pharmaceuticals Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available